Disease mechanisms and treatments
Radioactive drugs strike cancer with precision
The tumor-seeking radiopharmaceuticals are charting a new course in oncology, with promise for targeted treatments with fewer side effects.
New study discovers tiny target on RNA to short-circuit inflammation
Paper details high-throughput process for rapid screening, identification of mysterious ‘long non-coding RNA.’
How to control chronic wasting disease
A prion sickness similar to mad cow is spreading rapidly through North America’s deer and elk populations. A veterinary microbiologist discusses the options for keeping it in check.
New gene new strides in gangliosidosis
A gene that decreases disease progression in mice provides a new direction for human therapy.
Newly discovered genetic variant clarifies why Parkinson’s develops
Researchers at the University of Florida have found that the mutation called RAB32 Ser71Arg both causes the condition and could show how to halt it.
Illuminating the dark serum immunoglobulome
Researchers in the Netherlands shine a light on unique antibody repertories of severe COVID-19 patients.
'Protein sandwich' could transform cancer drug discovery
A team led by Alessio Ciulli has defined a new class of so-called “intramolecular bivalent glue,” which binds proteins that would otherwise stay apart.
What’s next in the Ozempic era?
Diabetes, weight loss and now heart health: A new family of drugs is changing the way scientists are thinking about obesity — and more uses are on the horizon.
New surfactant could improve lung treatments for premature babies
Researchers report progress toward an alternative to animal-derived formulation.